Crohn's disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice.

MLA

Santiago, Alba, et al. “Crohn’s Disease Proteolytic Microbiota Enhances Inflammation through PAR2 Pathway in Gnotobiotic Mice.” Gut Microbes, vol. 15, no. 1, Jan. 2023, p. 2205425. EBSCOhost, https://doi.org/10.1080/19490976.2023.2205425.

APA

Santiago, A., Hann, A., Constante, M., Rahmani, S., Libertucci, J., Jackson, K., Rueda, G., Rossi, L., Ramachandran, R., Ruf, W., Schertzer, J., Caminero, A., Bercik, P., Galipeau, H. J., & Verdu, E. F. (2023). Crohn’s disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice. Gut Microbes, 15(1), 2205425. https://doi.org/10.1080/19490976.2023.2205425

Chicago

Santiago, Alba, Amber Hann, Marco Constante, Sara Rahmani, Josie Libertucci, Kyle Jackson, Gaston Rueda, et al. 2023. “Crohn’s Disease Proteolytic Microbiota Enhances Inflammation through PAR2 Pathway in Gnotobiotic Mice.” Gut Microbes 15 (1): 2205425. doi:10.1080/19490976.2023.2205425.